Abstract

BackgroundThe established scoring system of radiographic sacroiliitis implemented in the mNY criteria for ankylosing spondylitis (AS) does not differentiate between different types of structural damage and does not account for...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand.
Matthew A Brown ... Stephen Stuckey
Journal of medical imaging and radiation oncology | VOL. 61
Matthew A Brown, et. al.Matthew A Brown ... Stephen Stuckey
19 Dec 2016
Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis.
Robert G Lambert ... David Sandoval
The Lancet. Rheumatology | VOL. 4
Robert G Lambert, et. al.Robert G Lambert ... David Sandoval
01 Sep 2022
Magnetic resonance imaging changes of sacroiliac joints in patients with recent-onset inflammatory back pain: inter-reader reliability and prevalence of abnormalities
Désirée Van Der Heijde ... Sjef Van Der Linden
Arthritis Research & Therapy | VOL. 8
Désirée Van Der Heijde, et. al.Désirée Van Der Heijde ... Sjef Van Der Linden
01 Dec 2005
OP0025 Identification of predictors of structural damage progression in the sacroiliac joints in patients with early axial spondyloarthritis on a long-term anti-tnf treatment
D Poddubnyy ... H Haibel
Annals of the Rheumatic Diseases | VOL. 77
D Poddubnyy, et. al.D Poddubnyy ... H Haibel
01 Jun 2018
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers